Show simple item record

dc.contributor.authorSheridan, G A
dc.contributor.authorMellon, L
dc.contributor.authorThompson, E M
dc.contributor.authorO'Kane, G M
dc.contributor.authorO'Toole, G C
dc.date.accessioned2023-06-15T14:27:48Z
dc.date.available2023-06-15T14:27:48Z
dc.date.issued2020-12-16
dc.identifier.issn0332-3102
dc.identifier.pmid32311251
dc.identifier.urihttp://hdl.handle.net/10147/635880
dc.description.abstractAims To investigate whether pathological fractures impact on osteosarcoma patient prognosis in Ireland. Methods This was a retrospective study over 22 years in a National Orthopaedic Oncology Centre. There were 117 nonfracture cases and 15 fracture cases. Outcome measures included 5 and 10 year event-free (EFS) and overall survival (OS). Kaplan-Meier curves assessed length of survival and time to death. Results Pathological fracture has no significant effect on 10 year EFS or 10 year OS. 3 factors strongly associate with 10 year OS rates: American Joint Committee on Cancer (AJCC) classification (p<0.001), Metastases site (p<0.001) and Distant recurrence (p<0.001). Fractures had poorer post-chemotherapeutic necrosis rates (p=0.005). Conclusion Pathological fractures have no significant effect on survival rates or length of survival in an Irish population. The effect of pathological fractures on necrosis rates must be explored in future research.en_US
dc.language.isoenen_US
dc.subjectOSTEOSARCOMAen_US
dc.subjectONCOLOGYen_US
dc.subjectORTHOPAEDICSen_US
dc.titlePrognostic Importance of Pathological Fractures in Osteosarcomas.en_US
dc.typeArticleen_US
dc.identifier.journalIrish medical journalen_US
dc.description.peer-reviewpeer-reviewen_US
dc.source.journaltitleIrish medical journal
dc.source.volume112
dc.source.issue10
dc.source.beginpage1021
dc.source.endpage
refterms.dateFOA2023-06-15T14:27:49Z
dc.source.countryIreland


Files in this item

Thumbnail
Name:
Prognostic-Importance-of-Patho ...
Size:
728.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record